BioSmart Research, Inc.
BioSmart Research: Invest in the future of cannabinoid therapy.
https://wefunder.com/biosmart.research.inc
Total raised on Wefunder: 53200
Total investors: 21
Quick facts
- Launch in 2019 produced $1.7M in sales
- Biosmart produces pain management and anti-anxiety formulas for clinical and retail distribution
- BioSmart has a 3-year technology lead using high-pressure liquid chromatography for isolate extraction
- BioSmart markets through it's own retail dispensaries, healthcare providers, pharmacies, affiliates, and internet sales
- U.S. Market for non-steroidal OTC pain relievers is $21.9 B/yr. US CBD market is $4.7 B/yr.
- Clinical dosing levels with CBD isolates produce similar results to OTC pain relievers without the side effects.
- BioSmart collaborates with university and clinical researchers and is a member of Choose Wisely, a patient forum
- BioSmart Research represents a responsible approach to improving quality of life and advancing cannabinoid research
Team profiles
Featured investor profiles
BioSmart Research, Inc.
BioSmart Research: Invest in the future of cannabinoid therapy
Last Funded December 2021
$53,200
raised from 21 investors
Pitch Video
Investor Panel